Aung KoKo, Lorenzo Carlos, Hinojosa Marco A, Haffner Steven M
Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.
J Clin Endocrinol Metab. 2014 Feb;99(2):462-8. doi: 10.1210/jc.2013-2832. Epub 2013 Nov 20.
CONTEXT: The risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) associated with obesity appears to be influenced by the coexistence of other metabolic abnormalities. OBJECTIVE: We examined the risk of developing CVD and DM in metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUH-NW) individuals. DESIGN AND SETTING: We analyzed prospective data of the San Antonio Heart Study, a population-based study among Mexican Americans and non-Hispanic whites (median follow-up, 7.4 y). PARTICIPANTS: Incident DM and CVD were assessed in 2814 and 3700 participants aged 25 to 64 years, respectively. MAIN MEASURES: MHO was defined as obesity (body mass index ≥ 30 kg/m(2)) with no more than one metabolic abnormality, and MUH-NW was defined as body mass index <25 kg/m(2) with two or more abnormalities. RESULTS: In logistic regression models, BMI was associated with incident DM after controlling for demographics, family history of DM, and fasting glucose (odds ratio × 1 SD, 1.7 [95% CI, 1.5-2.0]). Both MUH-NW and MHO individuals had an increased DM risk (2.5 [1.1-5.6] and 3.9 [2.0-7.4], respectively). Similarly, BMI was related to incident CVD after adjusting for demographics and Framingham risk score (1.3 [1.1-1.6]). Incident CVD was also increased in MUH-NW and MHO individuals (2.9 [1.3-6.4] and 3.9 [1.9-7.8], respectively). Results were consistent across gender and ethnic categories. CONCLUSION: The risk of developing DM and CVD is increased in MUH-NW and MHO individuals. Screening for obesity and other metabolic abnormalities should be routinely performed in clinical practice to institute appropriate preventive measures.
背景:与肥胖相关的心血管疾病(CVD)和2型糖尿病(DM)风险似乎受其他代谢异常共存的影响。 目的:我们研究了代谢健康的肥胖(MHO)和代谢不健康的正常体重(MUH-NW)个体发生CVD和DM的风险。 设计与地点:我们分析了圣安东尼奥心脏研究的前瞻性数据,这是一项针对墨西哥裔美国人及非西班牙裔白人的人群研究(中位随访时间为7.4年)。 参与者:分别对2814名年龄在25至64岁的参与者评估了新发DM情况,对3700名参与者评估了新发CVD情况。 主要测量指标:MHO定义为肥胖(体重指数≥30kg/m²)且代谢异常不超过一项,MUH-NW定义为体重指数<25kg/m²且存在两项或更多异常。 结果:在逻辑回归模型中,在控制了人口统计学因素、DM家族史和空腹血糖后,BMI与新发DM相关(优势比×1个标准差为1.7 [95%可信区间,1.5 - 2.0])。MUH-NW和MHO个体发生DM的风险均增加(分别为2.5 [1.1 - 5.6]和3.9 [2.0 - 7.4])。同样,在调整了人口统计学因素和弗雷明汉风险评分后,BMI与新发CVD相关(1.3 [1.1 - 1.6])。MUH-NW和MHO个体发生新发CVD的情况也增加(分别为2.9 [1.3 - 6.4]和3.9 [1.9 - 7.8])。结果在性别和种族类别中均一致。 结论:MUH-NW和MHO个体发生DM和CVD的风险增加。临床实践中应常规筛查肥胖及其他代谢异常,以采取适当的预防措施。
Medicine (Baltimore). 2020-9-18
BMJ Open Diabetes Res Care. 2025-5-28
Nutrients. 2025-2-20
Diabetes Metab Syndr Obes. 2024-3-18
Curr Osteoporos Rep. 2024-4
J Clin Endocrinol Metab. 2013-4-4
Clin Endocrinol (Oxf). 2013-5-11
Curr Opin Endocrinol Diabetes Obes. 2012-10
J Clin Endocrinol Metab. 2012-4-16